Aju IB Investment Co (027360) Fair Value & Analysis
Financials · KR · Market cap 974B KRW
Analysis
Aju IB Investment Co (027360) currently trades at 5,000 KRW, while our model-based Fair Value estimate is 910.91 KRW — implying the stock looks roughly 81.8% overvalued today. We read business quality at 95/100 (high quality), in the Financials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Aju IB Investment Co., Ltd. is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea. The firm considers investments in information technology including mobile service platforms, software, semiconductor, contents, biotechnology, life science, and environment sectors. For venture capital investments, it focuses on high technology sector and for private equity investments, the firm focuses on manufacturing sector. It typically invests in South Korea but also makes investments in other countries. The firm also considers investments in companies with main business in immune system platform technology, oncology drugs, and ophthalmic drugs. It also invests in information communication technology including Internet of Things, artificial intelligence, smart car, and advanced materials. The firm considers investments i…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.